From a clinical point of view, patients with relapsing MS have been found to have peripheral blood mononuclear cells (PBMCs) with higher expressions of NLRP3, caspase-1 and IL-1β compared to the healthy controls. Here, NLRP3 is linked to myeloid sarcoma.